IGI Logo

Chosen, and Hard to Displace

PB Fintech (POLICYBZ IN), via its flagship platform Policybazaar, has transformed India's insurance distribution by shifting a fragmented, agency-led market toward a scalable, technology-enabled ecosystem. By addressing core industry frictions – high customer acquisition cost, low-quality leads, weak conversion rates, and inconsistent servicing – the company has progressed from a comparison portal to a strategic distribution and data partner for insurers. Its expanding capabilities across customer acquisition, risk selection, underwriting support, profit-sharing arrangements, and healthcare enablement deepen its right-to-win (RTW) and position it to capture the benefits of rising insurance penetration in India. We initiate on POLICYBZ with a Buy rating and a DCF-derived TP of INR 1,990. This implies ~23% upside, and it is underpinned by an implicit valuation of 61x FY28E P/E

Policybazaar continues to strengthen RTW: Policybazaar is solidifying its RTW by becoming a strategic partner for insurers that source higher-quality customers at lower acquisition cost while improving conversion and portfolio profitability. Its technology stack, proprietary consumer data, and intelligent "best-match" algorithm are increasingly embedded in insurer workflows. Expanding capabilities in behavioral risk profiling, underwriting support, and, importantly, profit-sharing arrangements that align Policybazaar’s economics with business quality deepen insurer dependence and create a hard-to-replicate moat.

Paisabazaar poised to benefit from a strategic turnaround: In a crowded credit marketplace, Paisabazaar is shifting from a pure lead-generator to a value-added model focused on lender economics, borrower quality, and monetization. Enhanced risk analytics, borrower segmentation, and tighter lender integration are improving conversion and engagement. With management targeting a profitability inflection in FY27, we view Paisabazaar as incremental optionality that could become a medium-term growth driver as it scales up

Renewal income to drive a non-linear earnings trajectory: POLICYBZ is moving into a structurally different profitability phase as recurring renewal commissions – a high-margin, annuity-like stream – taking up a larger share of earnings. As the installed policy base compounds, renewal income should outgrow new business premium, enhancing earnings quality, and lowering dependence on acquisition spend. Together with operating leverage from a more variable cost base and a richer, health-led product mix, this should drive a multifold expansion in operating profit across our forecast horizon.

Initiate with a Buy rating and TP of INR 1,990: We initiate on POLICYBZ with a Buy rating and a DCF-derived TP of INR 1,990. This implies ~23% upside, and it is underpinned by an implicit valuation of 61.0x FY28E P/E vs the stock’s current 49.5x FY28E P/E. We expect a revenue CAGR of 33% and a PAT CAGR of 51% during FY26-29E with EBITDA margin expansion to 17.9% by FY29E, driven by improving operating leverage. Policybazaar's expanding role across the value chain, together with Paisabazaar as an emerging profitability lever, positions it strongly in an underpenetrated insurance market. We believe any material reduction in intermediaries’ payout by insurers would be a key risk to our estimates.

Please refer disclaimer at Report
SEBI Registration number is INH000000933